In our analysis one of the BRCA1, BRCA2, RAD51C, and PALB2 mutations was found in 25.8% of familial cancer cases and in 9.9% of non-familial cases, similar to what has been reported previously [18,33,40,41]. This evidence concerns the gene BRCA2 and hereditary cancer.